You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thymoglobulin

Showing 1 - 25 of 428
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy Trial in Lyon, Pierre-Bénite (Thymoglobulin 25

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy
  • Thymoglobulin 25 milligrams (mg) Injection
  • blood test
  • Lyon, France
  • +1 more
Feb 15, 2023

Heart Transplantation Trial in Los Angeles (Thymoglobulin, Mycophenolate Mofetil, Tacrolimus)

Enrolling by invitation
  • Heart Transplantation
  • Thymoglobulin
  • +4 more
  • Los Angeles, California
  • +1 more
Nov 11, 2022

Graft-versus-host-disease, Relapse Trial in Calgary (Treatment Arm - high dose ATG, Control Arm - standard of care)

Recruiting
  • Graft-versus-host-disease
  • Relapse
  • Treatment Arm - high dose ATG
  • Control Arm - standard of care
  • Calgary, Alberta, Canada
    Tom Baker Cancer Centre
Oct 14, 2022

GVHD Trial (Grafalon, Thymoglobulin)

Not yet recruiting
  • GVHD
  • (no location specified)
Oct 9, 2023

Hematological Malignancy Trial (Thymoglobulin Injectable Product)

Not yet recruiting
  • Hematological Malignancy
  • Thymoglobulin Injectable Product
  • (no location specified)
Sep 27, 2023

Diabetes, Type 1 Trial (Antithymocyte Globulin, Placebo (for ATG))

Recruiting
  • Diabetes Mellitus, Type 1
  • Antithymocyte Globulin
  • Placebo (for ATG)
  • Gainesville, Florida
    University of Florida
Jan 5, 2023

Thymoglobulin Versus Basiliximab on Regulatory T Cell Function

Suspended
  • KIDNEY TRANSPLANTATION
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 30, 2021

CD8+ CMV-specific Cellular Immunity in Renal Transplant Patients

Completed
  • Renal Transplant Infection
  • Thymoglobulin
  • Córdoba, Spain
    Hosìtal Universitario Reina Sofia
Jul 19, 2021

Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Stem cell infusion
  • +5 more
  • Saint Louis, Missouri
    Washington University
Jan 17, 2023

Pediatric Induction Therapy in Kidney Transplantation

Completed
  • Kidney Transplant Rejection
  • Pediatric Kidney Disease
  • Basiliximab Injection
  • rabbit ATG
  • Guangzhou, Guangdong, China
  • +4 more
Oct 15, 2023

Acute Renal Failure Trial in Burlington (Thymoglobulin, Thymoglobulin 0.75mg/kg dose)

Completed
Has Results
  • Acute Renal Failure
  • Thymoglobulin
  • Thymoglobulin 0.75mg/kg dose
  • Burlington, Massachusetts
    Lahey Clinic
Feb 23, 2021

Liver Failure Trial in United States (Thymoglobulin, Placebo)

Completed
Has Results
  • Liver Failure
  • Thymoglobulin
  • Placebo
  • Weston, Florida
  • +3 more
May 5, 2021

GVHD (GvHD) Trial in Cardiff (Thymoglobulin, Cyclophosphamide, Cyclosporine)

Recruiting
  • Graft Versus Host Disease (GvHD)
  • Thymoglobulin
  • +4 more
  • Cardiff, Wales, United Kingdom
    University Hospital of Wales
May 10, 2021

Absolute Uterine Infertility Trial in Dallas (Uterine Transplant)

Active, not recruiting
  • Absolute Uterine Infertility
  • Uterine Transplant
  • Dallas, Texas
    Baylor University Medical Center
Mar 7, 2022

Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)

Recruiting
  • Aplastic Anemia
  • Bone Marrow Failure Syndrome
  • Anti-Thymocyte Globulin (Rabbit)
  • +8 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 26, 2022

Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)

Withdrawn
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • nonmyeloablative allogeneic hematopoietic stem cell transplantation
  • +7 more
  • (no location specified)
Jan 4, 2023

Kidney Transplantation, Kidney Transplant Rejection Trial in Los Angeles (Twice-daily Tacrolimus, Once-daily envarsus XR,

Recruiting
  • Kidney Transplantation
  • Kidney Transplant Rejection
  • Twice-daily Tacrolimus
  • +5 more
  • Los Angeles, California
    University of Southern California
Jun 6, 2022

Crohn Disease Trial in Los Angeles (drug, procedure, biological)

Recruiting
  • Crohn Disease
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 23, 2022

GVHD Trial in Nantes (drug, radiation, other)

Terminated
  • Graft Versus Host Disease
  • Nantes, France
    Nantes Uh
Jul 13, 2022

Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

Recruiting
  • Hematologic Malignancy
  • Myeloid Malignancy
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Nov 7, 2022

Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)

Active, not recruiting
  • Refractory Non Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
  • rituximab
  • +7 more
  • Sacramento, California
    University of California Davis
Nov 28, 2022

Lung Transplant Trial in Los Angeles (thymoglobulin (intraoperative), thymoglobulin (postoperative))

Withdrawn
  • Lung Transplant
  • thymoglobulin (intraoperative)
  • thymoglobulin (postoperative)
  • Los Angeles, California
    Departments of Pulmonary and Critical Care, Cardiothoracic Surge
Sep 8, 2020

Kidney Transplant, Type 1 Diabetes Trial in Boston (Alpha 1-Antitrypsin, Islet Transplantation, Thymoglobulin)

Active, not recruiting
  • Kidney Transplant
  • Type 1 Diabetes
  • Alpha 1-Antitrypsin
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 15, 2021

Kidney Transplant Infection Trial in Córdoba (New profilaxis, Profilaxis recommended)

Completed
  • Kidney Transplant Infection
  • New profilaxis
  • Profilaxis recommended
  • Córdoba, Spain
    Hosìtal Universitario Reina Sofia
Jan 29, 2021

Sickle Cell Disease, Hemoglobinopathies Trial in Nashville (drug, procedure, radiation)

Active, not recruiting
  • Sickle Cell Disease
  • Hemoglobinopathies
  • Thymoglobulin
  • +7 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Dec 20, 2021